Early Access To Santheras Dmd Therapy Raxone Extended In The Uk | Latest News RSS feed

Early Access To Santheras Dmd Therapy Raxone Extended In The Uk - Latest News


Early access to Santhera’s DMD therapy Raxone extended in the UK

UK regulators have renewed the scientific opinion for Santhera’s Raxone, extending its availability to patients with Duchenne muscular dystrophy (DMD) through the Early Access to Medicines Scheme (EAM... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us